Asbestos–Related Pleuropulmonary Diseases: Benign and Malignant

References

• . O'Reilly KM, McLaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician. 2007;75(5):683–688
   PubMed Web of Science ®Google Scholar
• . Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S. Asbestos: when the dust settles—an imaging review of asbestos-related disease. Radiographics. 2002;22(spec no):S167–S84
   Google Scholar
• . US Department of the Interior. Asbestos in US Geological Survey. Minerals commodity summary, 2011. http://minerals.usgs.gov/minerals/pubs/commodity/asbestos/index.html. Accessed June 12, 2011
   Google Scholar
• . Cooke WE. Pulmonary asbestosis. BMJ. 1927;2(3491):1024–1025
   PubMedGoogle Scholar
• . Paustenbach DJ, Finley BL, Lu ET, . Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): a “state–of–the–art” review. J Toxicol Environ Health B Crit Rev. 2004;7(1):25–80
   PubMed Web of Science ®Google Scholar
• . Rosenberg DM. Asbestos-related disorders: A realistic perspective. Chest. 1997;111(5):1424–1426
   PubMedGoogle Scholar
• . LaDou J, Castleman B, Frank A, . The case for a global ban on asbestos. Environ Health Perspect. 2010;118(7):897–901
   PubMed Web of Science ®Google Scholar
• . Bartrip P. Too little, too late? The home office and the asbestos industry regulations, 1931. Medical History. 1998;42:421–438
   PubMed Web of Science ®Google Scholar
• . American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6):691–715
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Elimination of asbestos-related diseases. http://www.who.int/occupational_health/publications/asbestosrelateddiseases.pdf. Accessed June 11, 2011
   Google Scholar
• . Concha–Barrientos M, Nelson DI, Driscoll T, . Selected occupational risk factors. In: Ezzati M, , eds. Comparative quantification of health risks: global and regional burden of diseases attributable to selected major risk factors. Geneva, Switzerland; World Health Organization; 2004:1651–1801
   Google Scholar
• . Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39(7):576–588
   PubMed Web of Science ®Google Scholar
• . Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982;247(5):617–622
   PubMedGoogle Scholar
• . Robinson BW, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax. 1981;36(12):896–900
   PubMedGoogle Scholar
• . Paris C, Thierry S, Brochard P, ; National APEX Members. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J. 2009;34(1):72–79
   PubMed Web of Science ®Google Scholar
• . Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest. 2004;125:1103–1117
   PubMed Web of Science ®Google Scholar
• . International Labour Organization. The ILO International Classification of Radiographs of Pneumoconioses. Geneva, Switzerland: International Labour Organization; 2003
   Google Scholar
• . Friedman AC, Fiel SB, Fisher MS, Radecki PD, Lev–Toaff AS, Caroline DF. Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography. AJR. 1988;150(2):269–275
   PubMedGoogle Scholar
• . Mukherjee S, de Klerk N, Palmer LJ, Olsen NJ, Pang SC, Musk AW. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Resp Crit Care Med. 2000; 162(5):1807–1811
   PubMedGoogle Scholar
• . Shih J, Wilson JS, Broderick A, . Asbestos-induced pleural fibrosis and impaired exercise physiology. Chest. 1994;105(5):1370–1376
   PubMedGoogle Scholar
• . Miles SE, Sandrini A, Johnson AR, Yates DH. Clinical consequences of asbestos-related diffuse pleural thickening: a review. J Occup Med Toxicol. 2008;3:20
   PubMedGoogle Scholar
• . Bianchi, Brollo A, Ramani L, Zuch C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med. 1997;32(5):445–449
   PubMedGoogle Scholar
• . Yates DH, Browne K, Stidolph PN, Neville E. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Resp Crit Care Med. 1996; 153(1):301–306
   PubMedGoogle Scholar
• . Singh B, Eastwood PR, Finucane KE, Panizza JA, Musk AW. Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. Am J Respir Crit Care Med. 1999;160(5 pt 1): 1507–1515
   PubMedGoogle Scholar
• . Kurata S, Ishibashi M, Azuma K, . Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease. JPN J Radiol. 2010;28(6):446–452
   PubMedGoogle Scholar
• . Boraschi P, Neri S, Braccini G, Gigoni R, Leoncini B, Perri G. Magnetic resonance appearance of asbestos-related benign and malignant pleural disease. Scand J Work Environ Health. 1999;25(1):18–23
   PubMedGoogle Scholar
• . Jantz MA, Antony VB. Pleural fibrosis. Clin Chest Med. 2006;27(2): 181–191
   PubMed Web of Science ®Google Scholar
• . Chapman SJ, Cookson WO, Musk AW, Lee YC. Benign asbestos pleural effusion. Curr Opin Pulm Med. 2003;9(4):266–271
   PubMedGoogle Scholar
• . Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990;142(4):843–847
   PubMedGoogle Scholar
• . Sahn SA, Antony VB. Pathogenesis of pleural plaques. Relationship of early cellular response and pathology. Am Rev Resp Dis. 1984;130(5):884–887
   PubMedGoogle Scholar
• . Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722
   PubMed Web of Science ®Google Scholar
• . Blesovsky A. The folded lung. Br J Dis Chest. 1966;60(1):19–22
   PubMedGoogle Scholar
• . Hillerdal G. Rounded atelectasis: clinical experience with 74 patients. Chest. 1989;95(4):836–841
   PubMedGoogle Scholar
• . Dernevik L, Gatzinsky P. Pathogenesis of shrinking pleuritis with atelectasis—rounded atelectasis. Eur J Resp Dis. 1987; 71(4):244–249
   PubMedGoogle Scholar
• . Arakawa H, Honma K, Saito Y, . Pleural disease in silicosis: pleural thickening, effusion, and invagination. Radiology. 2005;236(2):685–693
   PubMedGoogle Scholar
• . Churg A, Wright JL. Persistence of natural mineral fibers in human lungs: an overview. Environ Health Perspect. 1994;102( suppl 5): 229–233
   PubMed Web of Science ®Google Scholar
• . Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5 pt 1): 1666–1680
   PubMed Web of Science ®Google Scholar
• . Kilburn KH, Warshaw RH. Severity of pulmonary asbestosis as classified by International Labour Organisation profusion of irregular opacities in 8749 asbestos-exposed American workers. Those who never smoked compared with those who ever smoked. Arch Intern Med. 1992;152(2):325–327
   PubMedGoogle Scholar
• . Gylseth B, Churg A, Davis JM, . Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial. Scand J Work Environ Health. 1985;11(2): 107–110
   PubMedGoogle Scholar
• . Fisher M, Günter S, Müller KM. Fibre-years, pulmonary asbestos burden and asbestosis. Int J Hyg Envirn Health. 2002;205(3): 245–248
   PubMedGoogle Scholar
• . Centers for Disease Control and Prevention (CDC). Asbestosis-related years of potential life lost before age 65 years—United States, 1968–2005. MMWR Morb Mortal Wkly Rep. 2008;57(49);1321–1325
   PubMedGoogle Scholar
• . Liu G, Beri R, Mueller A, Kamp DW. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. Chem Biol Interact. 2010;188(2):309–318
   PubMedGoogle Scholar
• . Dunn MM. Asbestos and the lung. Chest. 1989(6):1304–1308
   Google Scholar
• . Antonescu–Turcu AL, Schapira RM. Parenchymal and airway diseases caused by asbestos. Curr Opin Pulm Med. 2010;16(2):155–161
   PubMedGoogle Scholar
• . Lazarus AA, Philip A. Asbestosis. Dis Mon. 2011;57(1):14–28
   PubMedGoogle Scholar
• . Alfonso HS, Fritschi L, de Klerk NH, Olsen N, Sleith J, Musk AW. Effects of asbestos and smoking on the levels and rates of change of lung function in a crocidolite exposed cohort in Western Australia. Thorax. 2004;59(12):1052–1056
   PubMedGoogle Scholar
• . Brodkin CA, Barnhart S, Checkoway H, Balmes J, Omenn GS, Rosenstock L. Longitudinal pattern of reported respiratory symptoms and accelerated ventilator loss in asbestos-exposed workers. Chest. 1996;109(1):120–126
   PubMedGoogle Scholar
• . Lee YC, Singh B, Pang SC, de Klerk NH, Hillman DR, Musk AW. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003;60(3):201–206
   PubMedGoogle Scholar
• . Vathesatogkit P, Harkin TJ, Addrizzo–Harris DJ, Bodkin M, Crane M, Rom WN. Clinical correlation of asbestos bodies in BAL fluid. Chest. 2004;126(3):966–971
   PubMedGoogle Scholar
• . Pancoast HK, Miller TG, Landris HRM. A roentgenologic study of the effects of dust inhalation on the lung. Trans Assoc Am Physicians. 1917; 32:97–108
   Google Scholar
• . Batra P, Brown K, Hayashi K, Mori M. Rounded atelectasis. J Thor Imaging. 1996;11(3):187–197
   PubMedGoogle Scholar
• . International Labour Organization. Guidelines for the use of the ILO International Classification of Radiographs of Pneumoconioses. 2002. http://www.ilo.org/public/libdoc/ilo/2002/102B09_423_engl.pdf. Accessed June 12, 2011
   Google Scholar
• . Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med. 1978;298(17):934–939
   PubMed Web of Science ®Google Scholar
• . Roggli VL, Gibbs AR, Attanoos R, . Pathology of asbestosis—an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134(3):462–480
   PubMedGoogle Scholar
• . Ramazzini C. Asbestos is still with us: repeat call for a universal ban. Am J Ind Med. 2011;54(2):168–173
   PubMedGoogle Scholar
• . Dalichau S, Demedts A, im Sande A, Möller T. Short- and long-term effects of the outpatient medical rehabilitation for patients with asbestosis [in German]. Pneumologie. 2010;64(3):163–170
   PubMedGoogle Scholar
• . Addrizzo–Harris DJ, Harkin TJ, Tchou–Wong KM, . Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis. Lung. 2002;180(2):61–72
   PubMedGoogle Scholar
• . Antao VC, Pinheiro GA, Wassell JT. Asbestosis mortality in the USA: facts and predictions. Occup Environ Med. 2009;66(5):335–338
   PubMedGoogle Scholar
• . Smith DR, Leggat PA. 24 years of pneumoconiosis mortality surveillance in Australia. J Occup Health. 2006;48(5):309–313
   PubMedGoogle Scholar
• . Joshi TK, Gupta RK. Asbestos in developing countries: magnitude of risk and its practical implications. Int J Occup Med Environ Health. 2004; 17(1):179–185
   PubMedGoogle Scholar
• . Kazan–Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer. 2005;49( suppl 1):S3–S8
   PubMed Web of Science ®Google Scholar
• . Reid A, de Klerk N, Ambrosini G, . The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med. 2005;62(12):885–889
   PubMedGoogle Scholar
• . Hessel PA, Gamble JF, McDonald JC, . Asbestosis and lung cancer: a critical assessment of the epidemiological evidence. Thorax. 2005;60(5):433–436
   PubMedGoogle Scholar
• . Harding AH, Darnton A, Wegerdt J, McElvenny D. Mortality among British asbestos workers undergoing regular medical examinations (1971–2005). Occup Environ Med. 2009;66(7):487–495
   PubMedGoogle Scholar
• . Gan WQ, Demers PA, McLeod CB, Koehoorn M. Population-based asbestosis surveillance in British Columbia. Occup Env Med. 2009; 66(11):766–771
   PubMedGoogle Scholar
• . Schneider J, Bitterlish N, Kotschy–Lang N, Raab W, Woitowitz H. A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients. Anticancer Res. 2007;27(4A): 1869–1877
   PubMedGoogle Scholar
• . www.ClinicalTrials.gov. “Asbestos” and “Asbestosis.” US National Institutes of Health. Accessed June 11, 2011
   Google Scholar
• . Syslová K, Kačer P, Kuzma M, . LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. J Breath Res. 2010;4(1):017104
   Google Scholar
• . National Comprehensive Cancer Network. Practice Guidelines in Oncology: Malignant Pleural Mesothelioma. Version 2.2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed November 15, 2011
   Google Scholar
• . Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 2007;109(7):1432–1438
   PubMed Web of Science ®Google Scholar
• . Howell D, Arblaster L, Swinburne L, Schweiger M, Renvoize E, Hatton P. Routes of asbestos exposure and the development of mesothelioma in an English region. Occup Environ Med. 1997;54(6): 403–409
   PubMedGoogle Scholar
• . Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, associations or causality. Nat Rev Cancer. 2002;2(12):957–964
   PubMedGoogle Scholar
• . Mason R. Disorders of the pleura. Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia, PA: Elsevier Health Sciences; 2005;1994–2002
   Google Scholar
• . Leslie KO, Wick MR. Malignant and borderline mesothelial tumors of the pleura. Practical Pulmonary Pathology. 1st ed. 2005;734–767
   Google Scholar
• . British Thoracic Standards of Care Committee. BTS statement on malignant mesothelioma in the UK. Thorax. 2007;62( suppl 2):ii1–ii19
   PubMedGoogle Scholar
• . Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol. 1990;154(3):487–492
   PubMed Web of Science ®Google Scholar
• . Duysinx B, Nguyen D, Louis R, . Evaluation of pleural disease with 18-fuorodeoxyglucose positron emission tomography imaging. Chest. 2004;125(2):489–493
   PubMed Web of Science ®Google Scholar
• . Bérnard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of MPM and FDG-PET. Chest. 1998; 114(3):713–722
   PubMedGoogle Scholar
• . Rice DC, Erasmus JJ, Stevens CW, . Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surgery. 2005;80(6):1988–1993
   PubMed Web of Science ®Google Scholar
• . Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2003;126(1):11–16
   PubMedGoogle Scholar
• . Rice DC, Stevens CW, Correa AM, . Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007;84(5):1685–1693
   PubMed Web of Science ®Google Scholar
• . Pistolesi M, Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest. 2004;126(4):1318–1329
   PubMedGoogle Scholar
• . Ray M, Kindler HL. Malignant pleural mesothelioma: an update on biomarkers and treatment. Chest. 2009;136(3):888–896
   PubMed Web of Science ®Google Scholar
• . Robinson BW, Creaney J, Lake R, . Mesothelin-family proteins and diagnosis of mesothelioma. Lancet. 2003;362(9396):1612–1616
   PubMed Web of Science ®Google Scholar
• . Pass HI, Ltot D, Lonardo F, . Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med. 2005; 353(15):1564–1573
   PubMed Web of Science ®Google Scholar
• . Creaney J, Yeoman D, Demelker Y, . Comparison of osteopontin, MPF, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. J Thorac Oncol. 2008;3(8):851–857
   PubMedGoogle Scholar
• . Flores RF, Pass HI, Seshan VE, . Extra-pleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620–626
   PubMed Web of Science ®Google Scholar
• . Treasure T, Tan C, Lang–Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg. 2006;5(1):58–59
   PubMedGoogle Scholar
• . Lerner HJ, Schoenveld DA, Martin A, Falkson G, Borden E. Malignant mesothelioma: The Eastern Cooperative Oncology Group (ECOG) Experience. Cancer. 1983;52(11):1981–1985
   PubMedGoogle Scholar
• . Berghmans T, Paesmans M, Lalami Y, . Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of literature with meta-analysis. Lung Cancer. 2002;38(2):111–121
   PubMed Web of Science ®Google Scholar
• . Kindler HL. Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol. 2008;9(2–3):171–179
   PubMed Web of Science ®Google Scholar
• . Vogelzang NJ, Rusthoven JJ, Symanowski J, . Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636–2644
   PubMed Web of Science ®Google Scholar
• . Castagneto B, Botta M, Aitini E, . Phase II study of pemetrexed in combination with carboplatin in patients with MPM. Ann Oncol. 2008;19(2):370–373
   PubMed Web of Science ®Google Scholar
• . Lee CW, Murray N, Anderson H, Rao SC, Bishop W. Outcomes with a platinum plus a gencitabine or pemetrexed as first line therapy for MPM in British Columbia. Lung Cancer. 2009;64(3):308–313
   PubMedGoogle Scholar
• . Stebbing J, Powles T, McPherson K, . The effcacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer. 2009;63(1):94–97
   PubMed Web of Science ®Google Scholar
• . Krug LM, Pass HI, Rusch VW, . Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(18):3007–3013
   PubMed Web of Science ®Google Scholar
• . Tsao AS, Mehran R, Roth JA. Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma. Clin Lung Cancer. 2009;10(1):36–41
   PubMedGoogle Scholar
• . Molnar–Kimber KL, Sterman DH, Chang M, . Impact of pre-existing and induced humoral and cellular immune response in an adenovirus-based gene therapy phase I trial for localized mesothelioma. Hum Gene Ther. 1998;9(14):2121–2133
   PubMedGoogle Scholar
• . Sterman DH. Gene therapy for malignant pleural mesothelioma. Hemat Oncol Clin North Am. 2005;19(6):1147–1173
   PubMedGoogle Scholar
• . Grégoire M. What's the place of immunotherapy in malignant mesothelioma treatments? Cell Adh Migr. 2010;4(1):153–161
   PubMed Web of Science ®Google Scholar
• . Rusch VW. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thoracic Cardiovasc Surg. 1997;9(4):367–372
   PubMedGoogle Scholar
• . Gupta V, Mychalczak B, Krug L, . Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005;63(4):1045–1052
   PubMed Web of Science ®Google Scholar
• . Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites: the controversy continues. Curr Opin Pulm Med. 2008;14(4):326–330
   PubMedGoogle Scholar
• . Allen AM, Czerminska M, Jänne PA, . Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65(3):640–645
   PubMed Web of Science ®Google Scholar
• . Davis SR, Tan L, Ball DL. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol. 1994;38(3):212–214
   PubMedGoogle Scholar
• . Spirtas R, Heineman EF, Bernstein L, . Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51(12):804–811
   PubMed Web of Science ®Google Scholar
• . Ribak J, Selikoff IJ. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med. 1992;49(10):732–735
   PubMedGoogle Scholar
• . Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am. 2003;12(3):605–621
   PubMedGoogle Scholar
• . Murray R. Asbestos: a chronology of its origins and health effects. Br J Ind Med. 1990;47(6):361–365
   PubMedGoogle Scholar
• . Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology. 2004;36(6):517–550
   PubMed Web of Science ®Google Scholar
• . Gloyne SR. Pneumoconiossis. A histological survey of necropsy material in 1205 cases. Lancet. 1951;1(6659): 810–814
   PubMedGoogle Scholar
• . Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955;12(2):81–86
   PubMedGoogle Scholar
• . Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188:22–26
   PubMed Web of Science ®Google Scholar
• . Harding AH, Darnton A, Wegerdt J, McElvenny D. Mortality among British asbestos workers undergoing regular medical examinations (1971–2005). Occup Environ Med. 2009;66(7):487–495
   PubMedGoogle Scholar
• . Sullivan PA. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect. 2007;115(4):579–585
   PubMed Web of Science ®Google Scholar
• . Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 1997;23(2):93–103
   PubMedGoogle Scholar
• . Cullen MR, Barnett MJ, Balmes JR, . Predictors of lung cancer among asbestos-exposed men in the beta-carotene and retinol efficacy trial. Am J Epidemiol. 2005;161(3):260–270
   PubMedGoogle Scholar
• . Banks DE, Sh R, McLarty J, . American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest. 2009;135(6):1619–1627
   PubMedGoogle Scholar
• . Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci. 1979;330:473–490
   PubMedGoogle Scholar
• . Lee PN. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med. 2001;58(3):145–153
   PubMedGoogle Scholar
• . Liddell FD. The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg. 2001;45(5):341–356
   PubMedGoogle Scholar
• . Lee BW, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med. 1998;157(3 pt 1):748–755
   PubMedGoogle Scholar
• . Karjalainen A, Anttila S, Heikkila L, Kyyronen P, Vainio H. Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health. 1993;19(2):102–107
   PubMedGoogle Scholar
• . Churg A. Lung cancer cell type and asbestos exposure. JAMA. 1985;253(20):2984–2985
   PubMed Web of Science ®Google Scholar
• . Heintz NH, Janssen–Heininger YM, Mossman BT. Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol. 2010;42(2): 133–139
   PubMed Web of Science ®Google Scholar
• . Linardou H, Dahabreh IJ, Kanaloupiti D, . Assessment of somatic k-RAS mutations as mechanisms associated with resistance to EGFR-targeted agents: a systemic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol. 2008;9(10):962–972
   PubMed Web of Science ®Google Scholar
• . Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT. K-ras mutation and occupational asbestos exposure in lung adencocarinoma: asbestos-related cancer without asbestosis. Cancer Res. 1999;59(18):4570–4573
   PubMed Web of Science ®Google Scholar
• . Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876): 674–677
   PubMed Web of Science ®Google Scholar
• . Oksa P, Klockars M, Karjalainen A, . Progression of asbestosis predicts lung cancer. Chest. 1998;113(6):1517–1521
   PubMedGoogle Scholar
• . Loomis D, Dement J, Richardson D, Wolf S. Asbestos fiber dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 2010;67(9):580–584
   PubMed Web of Science ®Google Scholar
• . McAdams HP, Erasmus JJ, Patz EF, Goodman PC, Coleman RE. Evaluation of patients with round atelectasis using 2-[18F]Fluoro-2-deoxy-D-glucose PET. J Comput Assist Tomogr. 1998;22(4): 601–604
   PubMedGoogle Scholar
• . Henderson DW. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Consensus report. Scand J Work Environ Health. 1997;23(4):311–316
   PubMedGoogle Scholar
• . Vierikko T, Jarvenpaa R, Autti T, . Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Respir J. 2007;29(1):78–84
   PubMedGoogle Scholar
• . Clin B, Morlais F, Guittet L, . Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. Occup Environ Med. 2009;66(8):529–534
   PubMedGoogle Scholar
• . Tossavainen A. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. Scand J Work Environ Health. 2000;26(5):449–454
   PubMedGoogle Scholar
• . Ghosal R, Kloer P, Lewis KE. A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J. 2009;85(1005):358–363
   PubMedGoogle Scholar
• . Lam B, Lam SY, Wong MP, . Sputum cytology examination followed by autoflurorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009;64(3):289–294
   PubMedGoogle Scholar
• . Loewen G, Natarajan N, Tan D, . Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax. 2007;62(4):335–340
   PubMedGoogle Scholar
• . MacMahon H, Austin JH, Gamsu G, ; Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237(2):395–400
   PubMed Web of Science ®Google Scholar
• . van Klaveren RJ, Oudkerk M, Prokop M, . Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361(23):2221–2229
   PubMed Web of Science ®Google Scholar
• . Bapoje SR, Whitaker JF, Schulz T, Chu ES, Albert RK. Preoperative evaluation of the patient with pulmonary disease. Chest. 2007; 132(5):1637–1645
   PubMed Web of Science ®Google Scholar
• . Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323–329
   PubMed Web of Science ®Google Scholar
• . Ak G, Metintas M, Metintas S, . Characteristics of lung cancer patients with asbestos-related radiological findings. Tuberk Toraks. 2008;56(3):257–265
   PubMedGoogle Scholar